Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01EHW
|
||||
Former ID |
DIB006499
|
||||
Drug Name |
Antifibrinolytic agents
|
||||
Synonyms |
Antifibrinolytic agents (bleeding); Antifibrinolytic agents (bleeding), Omeros; Antifibrinolytic agents (bleeding), University of California; Selective plasmin inhibitors (bleeding), Omeros; Selective plasmin inhibitors (bleeding), University of California
|
||||
Indication | Bleeding [ICD9: 444, 453; ICD10:I74, I80-I82] | Investigative | [532368] | ||
Company |
University of California
|
||||
Target and Pathway | |||||
Target(s) | Plasminogen | Target Info | Inhibitor | [532368] | |
PANTHER Pathway | Blood coagulation | ||||
Plasminogen activating cascade | |||||
PathWhiz Pathway | Coagulation | ||||
WikiPathways | Complement and Coagulation Cascades | ||||
Human Complement System | |||||
Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||||
Activation of Matrix Metalloproteinases | |||||
Blood Clotting Cascade | |||||
Dissolution of Fibrin Clot | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.